Expression of cyclin D1, p27, p21, bcl-2, and p53 in laryngeal squamous cell carcinoma and an investigation of the correlation with conventional prognostic factors

Turkish Journal of Medical Sciences

Volumn 43, Issue 1, 2013, Pages 27-32

  Şimşek, Gülçin ^a   Han, Ünsal ^a   Önal, Binnur ^a   Köybaşioǧlu, Fatma Fulya ^a   Akin, Istemihan ^a   Daǧli, Muharrem ^a  

^a MINISTRY OF HEALTH   (Turkey)

Author keywords

Bcl 2; Cyclin D1; Larynx; P21; P27; P53; Squamous cell carcinoma

Indexed keywords

CYCLIN D1; PROTEIN BCL 2; PROTEIN P21; PROTEIN P27; PROTEIN P53;

AGE; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNGEAL SQUAMOUS CELL CARCINOMA; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MALE; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SEX; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 84872808574     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: 10.3906/sag-1202-104     Document Type: Article

References (27)

1. Rosai J. Larynx and trachea. In: Rosai J, editor. Ackerman's surgical pathology. 8th ed. New York: Mosby, 1996. p.321-8.
2. Almadori G, Galli J, Cadoni G, Bussu F, Maurizi M. Human papillomavirus infection and cyclin D1 gene amplification in laryngeal squamous cell carcinoma: biologic function and clinical significance. Head Neck 2002; 24: 597-604.
3. Vielba R, Bilbao J, Ispizua A, Zabalza I, Alfaro J, Rezola R et al. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx. Laryngoscope 2003; 113: 167-72.
4. Silvestri F, Bussani R, Stanta G, Cosatti C, Ferlito A. Supraglottic versus glottic laryngeal cancer. Epidemiological and pathological aspects. ORL J Otorhinolaryngol Relat Spec 1992; 54: 43-8.
5. Wiernick G, Millard PR, Haybittle JL. The predictive value of histologic classification into degrees of differentiation of squamous cell carcinoma of the larynx and hypopharynx compared with the survival of patients. Histopathology 1991; 19: 411-7.
6. Rafferty M, Helliwell TR, Husband DJ, Fenton J, Jones TM, Jones AS. Expression of cell cycle associated proteins influences radiocurability of T2N0 squamous cell carcinoma of the larynx. Oral Oncol 2008; 44: 975-81.
7. Barona de Guzman R, Martorell MA, Basterra J, Armengot M, Alvarez-Valdes R. Prognostic value of histopathological parameters in 51 supraglottic squamous cell carcinomas. Laryngoscope 1993; 103: 538-40.
8. Kocaturk S, Yi{dotless}lmazer D, Onal B, Erkam U, Urunal B. Do micrometastases detected with cytokeratin immunoperoxidase reactivity affect the treatment approach to neck in supraglottic cancers? Otolaryngol Head Neck Surg 2003; 128: 407-11.
9. Barona de zman R, Martorell MA, Basterra J, Armengot M, Alvarez-Valdes R, Garin L. Prognostic value of histopathological parameters in 51 supraglottic squamous cell carcinomas. Laryngoscope 2003; 103: 538-40.
10. Yi{dotless}lmaz T, Hosal AS, Gedikoǧlu G, Onerci M, Gursel B. Prognostic significance of vascular and perineural invasion in the cancer of the larynx. Am J Otolaryngol 1998; 19: 83-8.
11. Fagan JJ, Collins B, Barnes L, D'Amico F, Myers EN, Johnson JT. Perineural invasion in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1998; 124: 637-40.
12. Hucumenoǧlu S, Gumuşkaya B, Alper M, Ocal B, Karabulut E. Annexin A2, A7, and A11 expression in head and neck squamous cell carcinoma. Turk J Med Sci 2009; 39: 547-55.
13. Perisanidis C, Perisanidis B, Wrba F, Brandstetter A, El Gazzar S, Papadogeorgakis N et al. Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma. J Oral Pathol Med 2012; 41: 40-6.
14. Yoo SS, Carter D, Turner BC, Sasaki CT, Son YH, Wilson LD et al. Prognostic significance of cyclin D1 protein levels in early stage larynx cancer treated with primary radiation. Int J Cancer 2000; 90: 159-65.
15. Mielcarek-Kuchta D, Olofsson J, Golusinski W. p53, Ki67 and cyclin D1 as prognosticators of lymph node metastasis in laryngeal carcinoma. Eur Arch Otorhinolaryngol 2003; 260: 549-54.
16. Capaccio P, Pruneri G, Carboni N, Pagliari AV, Quatela M. Cyclin D1 expression is predictive of occult metastases in head and neck cancer patients with clinically negative cervical lymph nodes. Head Neck 2000; 22: 234-40.
17. Chrysovergis A, Gorgoulis VG, Giotakis I, Tsiambas E, Karameris A, Kittas C et al. Simultaneous over activation of EGFR, telomerase (h TERT), and cyclin D1 correlates with advanced disease in larynx squamous cell carcinoma: a tissue microarray analysis. Med Oncol 2011; 28: 871-7.
18. Bozkurt C, Bozkurt S, Arda N, Ertem AU, Şahin G, Yuksek N et al. P16 and p27 tumor suppressor gene methylation status in childhood Wilms tumor cases. Turk J Med Sci 2011; 41: 633-8.
19. Pruneri G, Pignataro L, Carboni N, Buffa R, Finizio D. Clinical relevance of expression of the CIP/KIP cell cycle inhibitors p21 and p27 in laryngeal cancer. J Clin Oncol 1999; 117; 3150-9.
20. Trask D, Wolf G, Bradford C, Fisher SG, Devaney K. Expression of bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation. Laryngoscope 2002; 112: 638-44.
21. Lazaris AC, Lendari I, Kavantzas N, Kandiloros D, Adamopoulos G, Davaris P. Correlation of tumor markers p53, bcl-2 and cathepsins-D with clinicopathologic features and disease-free survival in laryngeal squamous cell carcinoma. Pathol Int 2000; 50: 717-24.
22. Jackel MC, Sellman L, Youssef S, Dorudian MA, Fuzesi L. Prognostic significance of expression of p53, bcl-2 and bax in the squamous epithelial carcinoma of the larynx-a multivariate analysis. HNO 2001; 49: 204-11.
23. Condon LT, Ashman JN, Ell SR, Stafford ND, Greenman J, Cawkwell L. Overexpression of bcl-2 in squamous cell carcinoma of the larynx: a marker of radioresistance. Int J Cancer 2002; 100: 472-5.
24. Seckin S, Karagece U. Expression of CK-19, cErbB2, galectin-3, and p53 in papillary thyroid carcinomas. Turk J Med Sci 2010; 40: 207-12.
25. Alhan E, Cinel A, Ercin M C, Turkyi{dotless}lmaz S, Kural BV, Alper M et al. The effects of p53 inhibition using pifithrin-α on acute necrotizing pancreatitis in rats. Turk J Med Sci 2011, 41: 673-83.
26. Peschos D, Stefanou D, Vougiouklakis T, Assimakopoulos DA, Agnantis NJ. Cell cycle proteins in laryngeal cancer: role in proliferation and prognosis. J Exp Clin Cancer Res 2005; 24: 431-7.
27. Perez-Carro Rios A, Lozano Ramirez A, Garcia Caballero T, Labella T, Clemente Garcia A. An immunohistochemistry study of p53 protein in squamous cell carcinoma of the larynx. Acta Otorhinolaringol Esp 2003; 54: 263-8.